Drug intelligence / Profile preview

crespine

Development stage
Unknown
Lead developer
BioPolymer
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Intraarticular
01

Overview

Crespine is a sterile, viscoelastic intra-articular implant composed primarily of crosslinked hyaluronic acid. It is designed for single-use injection into joints affected by osteoarthritis—most commonly the knee and hip—to supplement or replace synovial fluid. The mechanism of action involves restoring joint lubrication and cushioning by mimicking natural synovial fluid properties, thereby reducing pain and improving mobility in patients with mild to moderate osteoarthritis. Some formulations (such as Crespine Gel Plus) also include prilocaine hydrochloride as a local anesthetic to reduce injection discomfort. The product uses non-animal-based hyaluronic acid to minimize allergic reactions and is intended for patients who have not responded adequately to oral medications or conservative therapies[1][2][3][4][5][6][7].

Brand names
CrespineCrespine GelCrespine Gel Plus
Other names
crespine gelcrespine gel plus
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on crespine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on crespine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call